CIBC Private Wealth Group, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 168 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
CIBC Private Wealth Group, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,493
-99.6%
26,239
+20.8%
0.00%
-100.0%
Q3 2019$337,000
-9.7%
21,7230.0%0.00%0.0%
Q2 2019$373,000
-17.1%
21,723
-22.2%
0.00%
-50.0%
Q1 2019$450,000
-4.5%
27,935
-13.2%
0.00%0.0%
Q4 2018$471,000
-14.2%
32,173
+6.4%
0.00%0.0%
Q3 2018$549,000
+26.2%
30,232
+17.3%
0.00%0.0%
Q2 2018$435,0000.0%25,766
+15.9%
0.00%0.0%
Q1 2018$435,000
-5.8%
22,225
-2.5%
0.00%0.0%
Q4 2017$462,000
+3.4%
22,801
-11.3%
0.00%0.0%
Q3 2017$447,000
+31.1%
25,718
-3.4%
0.00%0.0%
Q2 2017$341,000
+5.2%
26,625
+6.5%
0.00%0.0%
Q1 2017$324,000
+31.2%
25,0100.0%0.00%0.0%
Q4 2016$247,000
-1.2%
25,010
+20.8%
0.00%0.0%
Q3 2016$250,000
-19.9%
20,700
+15.1%
0.00%0.0%
Q4 2015$312,000
+39.3%
17,985
+7.6%
0.00%0.0%
Q3 2015$224,000
-51.9%
16,715
-19.0%
0.00%
-33.3%
Q2 2015$466,000
+73.9%
20,625
+9.9%
0.00%
+50.0%
Q1 2015$268,00018,7700.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders